KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to -$433.8 million.

  • Neogenomics' Retained Earnings fell 3315.88% to -$433.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$433.8 million, marking a year-over-year decrease of 3315.88%. This contributed to the annual value of -$433.8 million for FY2025, which is 3315.88% down from last year.
  • Per Neogenomics' latest filing, its Retained Earnings stood at -$433.8 million for Q4 2025, which was down 3315.88% from -$423.9 million recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Retained Earnings ranged from a high of $47.3 million in Q2 2021 and a low of -$433.8 million during Q4 2025
  • Its 5-year average for Retained Earnings is -$206.1 million, with a median of -$223.5 million in 2023.
  • Its Retained Earnings has fluctuated over the past 5 years, first skyrocketed by 28788.51% in 2021, then plummeted by 97223.16% in 2022.
  • Over the past 5 years, Neogenomics' Retained Earnings (Quarter) stood at -$14.8 million in 2021, then tumbled by 972.23% to -$159.1 million in 2022, then crashed by 55.3% to -$247.1 million in 2023, then crashed by 31.87% to -$325.8 million in 2024, then tumbled by 33.16% to -$433.8 million in 2025.
  • Its last three reported values are -$433.8 million in Q4 2025, -$423.9 million for Q3 2025, and -$396.8 million during Q2 2025.